AR018313A1 - ANTI-CONCEPTIVE KIT THAT INCLUDES MEANS FOR THE DAILY ADMINISTRATION OF AN ANTI-CONCEPTIVE AGENT, USE OF A STEROID COMPOUND THAT HAS A DEACTIVITY PROFILE THAT INHERENTLY COMBINES THE PROGESTAGENIC AND STROGENIC ACTIVITIES AND AN ANTI-PROCEPTIVE METHOD - Google Patents
ANTI-CONCEPTIVE KIT THAT INCLUDES MEANS FOR THE DAILY ADMINISTRATION OF AN ANTI-CONCEPTIVE AGENT, USE OF A STEROID COMPOUND THAT HAS A DEACTIVITY PROFILE THAT INHERENTLY COMBINES THE PROGESTAGENIC AND STROGENIC ACTIVITIES AND AN ANTI-PROCEPTIVE METHODInfo
- Publication number
- AR018313A1 AR018313A1 ARP990100933A ARP990100933A AR018313A1 AR 018313 A1 AR018313 A1 AR 018313A1 AR P990100933 A ARP990100933 A AR P990100933A AR P990100933 A ARP990100933 A AR P990100933A AR 018313 A1 AR018313 A1 AR 018313A1
- Authority
- AR
- Argentina
- Prior art keywords
- conceptive
- agent
- profile
- progestagenic
- kit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Un kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, donde el agente anticonceptivo unico es uncompuesto esteroide que tiene un perfil de actividad que combina inherentemente las actividades progestagénicas y estrogénica. Dentro de una clasegeneral de compuestos esteroidales conocidos, se han encontrado esteroides que tienen un perfil combinado destacado de propiedades biologicas para eluso en la anticoncepcion, especialmente por monoterapia. Estos esteroides se seleccionan del grupo que consiste en esteroides que satisfacen la formulaestructural (I) y prodrogas de los mismos, donde cada una de la líneas punteadas indica independientemente un enlace adicional opcional.A contraceptive kit comprising means for the daily administration of a contraceptive agent, where the unique contraceptive agent is a steroid compound that has an activity profile that inherently combines progestagenic and estrogenic activities. Within a general class of known steroidal compounds, steroids have been found that have a prominent combined profile of biological properties for contraceptive use, especially by monotherapy. These steroids are selected from the group consisting of steroids that satisfy the structural formula (I) and prodrugs thereof, where each of the dashed lines independently indicates an optional additional bond.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98200744 | 1998-03-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR018313A1 true AR018313A1 (en) | 2001-11-14 |
Family
ID=8233452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990100933A AR018313A1 (en) | 1998-03-09 | 1999-03-05 | ANTI-CONCEPTIVE KIT THAT INCLUDES MEANS FOR THE DAILY ADMINISTRATION OF AN ANTI-CONCEPTIVE AGENT, USE OF A STEROID COMPOUND THAT HAS A DEACTIVITY PROFILE THAT INHERENTLY COMBINES THE PROGESTAGENIC AND STROGENIC ACTIVITIES AND AN ANTI-PROCEPTIVE METHOD |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1061928A2 (en) |
| JP (1) | JP2002506014A (en) |
| KR (1) | KR20010041698A (en) |
| CN (1) | CN1292702A (en) |
| AR (1) | AR018313A1 (en) |
| AU (1) | AU756882B2 (en) |
| BR (1) | BR9908605A (en) |
| CA (1) | CA2319765A1 (en) |
| CO (1) | CO5070598A1 (en) |
| HU (1) | HUP0101007A3 (en) |
| ID (1) | ID25621A (en) |
| IL (1) | IL137541A0 (en) |
| NO (1) | NO20004492L (en) |
| NZ (1) | NZ506115A (en) |
| PE (1) | PE20000330A1 (en) |
| PL (1) | PL343428A1 (en) |
| RU (1) | RU2225714C2 (en) |
| TR (1) | TR200002593T2 (en) |
| WO (1) | WO1999045886A2 (en) |
| ZA (1) | ZA991851B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999051214A2 (en) * | 1998-04-07 | 1999-10-14 | Akzo Nobel N.V. | Progestogen-only contraceptive kit |
| MXPA02001831A (en) | 1999-09-06 | 2002-10-23 | Akzo Nobel Nv | Nonaromatic estrogenic steroids with a hydrocarbon substituent in position 11. |
| AU8201601A (en) | 2000-07-28 | 2002-02-13 | Akzo Nobel Nv | 16alpha-methyl or ethyl substituted estrogens |
| EP1482949A1 (en) * | 2002-03-11 | 2004-12-08 | Janssen Pharmaceutica N.V. | Sulfatase inhibiting progestogen-only contraceptive regimens |
| AU2003213842A1 (en) * | 2002-03-11 | 2003-09-29 | Janssen Pharmaceutica N.V. | Sulfatase inhibiting continuous progestogen contraceptive regimens |
| UA89964C2 (en) | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15beta-substituted steroids having selective estrogenic activity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7701384A (en) * | 1977-02-10 | 1978-08-14 | Akzo Nv | PROCESS FOR PREPARING NEW STEROIDS FROM THE OESTRAINE SERIES. |
| DE4227989A1 (en) * | 1992-08-21 | 1994-06-09 | Schering Ag | Agent for transdermal application containing 3-keto-desogestrel |
| ZA94715B (en) * | 1993-02-08 | 1994-10-24 | Akzo Nv | Steroids for treating menopausal complaints |
-
1999
- 1999-03-03 ID IDW20001715A patent/ID25621A/en unknown
- 1999-03-03 WO PCT/EP1999/001404 patent/WO1999045886A2/en not_active Application Discontinuation
- 1999-03-03 IL IL13754199A patent/IL137541A0/en unknown
- 1999-03-03 HU HU0101007A patent/HUP0101007A3/en unknown
- 1999-03-03 CN CN998037710A patent/CN1292702A/en active Pending
- 1999-03-03 PL PL99343428A patent/PL343428A1/en unknown
- 1999-03-03 BR BR9908605-0A patent/BR9908605A/en not_active IP Right Cessation
- 1999-03-03 JP JP2000535302A patent/JP2002506014A/en not_active Withdrawn
- 1999-03-03 CA CA002319765A patent/CA2319765A1/en not_active Abandoned
- 1999-03-03 KR KR1020007009917A patent/KR20010041698A/en not_active Application Discontinuation
- 1999-03-03 AU AU31437/99A patent/AU756882B2/en not_active Ceased
- 1999-03-03 NZ NZ506115A patent/NZ506115A/en unknown
- 1999-03-03 TR TR2000/02593T patent/TR200002593T2/en unknown
- 1999-03-03 RU RU2000125572/15A patent/RU2225714C2/en not_active IP Right Cessation
- 1999-03-03 EP EP99939157A patent/EP1061928A2/en not_active Withdrawn
- 1999-03-05 AR ARP990100933A patent/AR018313A1/en not_active Application Discontinuation
- 1999-03-08 ZA ZA9901851A patent/ZA991851B/en unknown
- 1999-03-08 CO CO99014138A patent/CO5070598A1/en unknown
- 1999-03-09 PE PE1999000186A patent/PE20000330A1/en not_active Application Discontinuation
-
2000
- 2000-09-08 NO NO20004492A patent/NO20004492L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20004492D0 (en) | 2000-09-08 |
| NO20004492L (en) | 2000-09-08 |
| WO1999045886A3 (en) | 1999-12-02 |
| ID25621A (en) | 2000-10-19 |
| AU756882B2 (en) | 2003-01-23 |
| RU2225714C2 (en) | 2004-03-20 |
| NZ506115A (en) | 2003-07-25 |
| JP2002506014A (en) | 2002-02-26 |
| AU3143799A (en) | 1999-09-27 |
| CO5070598A1 (en) | 2001-08-28 |
| PL343428A1 (en) | 2001-08-13 |
| TR200002593T2 (en) | 2000-12-21 |
| CN1292702A (en) | 2001-04-25 |
| BR9908605A (en) | 2001-04-24 |
| ZA991851B (en) | 1999-09-22 |
| HUP0101007A2 (en) | 2001-12-28 |
| WO1999045886A2 (en) | 1999-09-16 |
| IL137541A0 (en) | 2001-07-24 |
| CA2319765A1 (en) | 1999-09-16 |
| EP1061928A2 (en) | 2000-12-27 |
| KR20010041698A (en) | 2001-05-25 |
| PE20000330A1 (en) | 2000-05-16 |
| HUP0101007A3 (en) | 2002-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR7420A (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ONE OR VARIOUS STEROIDS, ONE OR VARIOUS COMPONENTS OF TETRAHIIDROPHOLATES AND VITAMIN B12 | |
| ES2191320T3 (en) | DERIVATIVES OF PIPERAZINE AND ITS USE AS ANTI-INFLAMMATORY AGENTS. | |
| TR200002774T2 (en) | Steroid sapogenes and their derivatives for the treatment of Alzheimer's disease | |
| EA200201000A1 (en) | HORMONE-DESTINY THERAPY | |
| ECSP066972A (en) | MUTUAL PROMOTES OF GLUCOSAMINE AND GLUCOSAMINE / ANTI-INFLAMMATORY, COMPOSITIONS, AND METHODS | |
| BRPI0517752A (en) | process for the preparation of drospirenone | |
| AR046671A1 (en) | EXTENDED USE OF COMBINATION THAT INCLUDES STROGENS AND PROGESTINES | |
| BRPI0512993A (en) | use of a pr antagonist, pharmaceutically useful kit, and method of contraception in a female of childbirth | |
| BR9911115A (en) | Pharmaceutical compositions and uses for oandrost-5-ene-3 beta, 17 beta-diol | |
| CR7611A (en) | USE OF CILOTIOCARBAMATE DERIVATIVES IN TREATMENT OF CONDITIONS RELATED TO HORMONE | |
| ITMI20040367A1 (en) | PROCESS FOR THE PREPARATION OF DROSPIRENONE | |
| ECSP044973A (en) | NEW CRYSTAL POLYMORPHIC FORMS OF LERCANIDIPINE CHLORHYDRATE AND PROCESS FOR PREPARATION | |
| PA8633601A1 (en) | STEROID PROPHARMS WITH ANDROGENIC ACTION | |
| AR018313A1 (en) | ANTI-CONCEPTIVE KIT THAT INCLUDES MEANS FOR THE DAILY ADMINISTRATION OF AN ANTI-CONCEPTIVE AGENT, USE OF A STEROID COMPOUND THAT HAS A DEACTIVITY PROFILE THAT INHERENTLY COMBINES THE PROGESTAGENIC AND STROGENIC ACTIVITIES AND AN ANTI-PROCEPTIVE METHOD | |
| CY1110173T1 (en) | USE OF (11 BETA, 17BETA) -11- (1,3-BENZODIOXOL-5-YL) -17-HYDROXY-17- (1-PROPYNYL) -ESTRA-4,9-DIEN-3-ONE IN MAJOR DEPARTMENT THERAPY Disturbance | |
| PT1421099E (en) | 17-ALPHA, 21-DIHYDROXYGENEAN ESTERS AS ANTI-ANDROGENIC AGENTS | |
| AR046672A1 (en) | PREVENTION AND TREATMENT OF HYPERTENSIVE CARDIAC DISEASES THROUGH THE USE OF SELECTIVE STROGENS 8BETA-VINIL-ESTRA-1,3,5 (10) -TRIEN-3,17BETA-DIOL AND 17BETA-FLUOR-9ALFA-VINIL-ESTRA-1,3 , 6 (10) -TRIEN-3.16ALFA-DIOL | |
| BR0013769A (en) | Non-aromatic Estrogen Steroids, Pharmaceutical Composition, and Use of a Steroid Compound | |
| AR040188A1 (en) | STRATRIENS 9-ALFA-SUBSTITUTED AS SELECTIVE EFFECTIVENESS STROGENS | |
| BR0116127A (en) | Compound, pharmaceutical composition, use of a compound, and, male contraceptive kit | |
| PE20020894A1 (en) | USE OF SELECTIVE LIGANDS FOR ERß TO REGULATE FERTILITY | |
| PE20020520A1 (en) | USE OF ANTIPROGESTINES FOR PROPHYLAXIS AND THE TREATMENT OF HORMONE-DEPENDENT DISEASES | |
| AR036257A1 (en) | SULFAMATES OF 2-ALCOXIESTRADIOL OF ANTITUMORAL ACTION | |
| ECSP972100A (en) | METHOD FOR TREATING INFLAMMATION | |
| EE200200302A (en) | Unsaturated 14,15-cyclopropanoandrostanes, process for their preparation and pharmaceutical compositions containing these compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |